Progress of clinical medication for esophageal cancer / 中国癌症杂志
China Oncology
; (12)2001.
Article
in Zh
| WPRIM
| ID: wpr-547280
Responsible library:
WPRO
ABSTRACT
The combination of chemotherapy,radiotherapy and surgery is the current main strategy for esophageal cancer,and chemotherapy plays a vital role in terms of prolongation of survival and quality of life.The development of new chemotherapeutic agents for the treatment of esophageal cancer has been given much attention in the past.This review summarized the effi cacy and safety of new agents based on clinical evidence and the roles of those agents in the multidisciplinary treatment of esophageal cancer.It also included the progress of molecular targeting therapy for the disease.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
China Oncology
Year:
2001
Type:
Article